Research indicates that leaky progesterone pessaries used in threatened miscarriage cases cost the NHS £236m in avoidable ...

Zevra Therapeutics’ Miplyffa approved for Niemann-Pick type C. Read why ZVRA stock presents both potential and risks for long-term investors.

April showers may bring May flowers, but in New York it brings 6 new laws on the books. Changes are coming for veterans, ...

Collaboration to apply Lunit’s AI technologies across NCI’s broad spectrum of cancer studies, aiming to accelerate personalized cancer ...

Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, ...

Nonradiologists interpreted 43.6% of office-based imaging studies in 2022, according to a study published April 2 in the ...

Denali Therapeutics, Inc. (NASDAQ:DNLI) shares traded higher on Wednesday after the company initiated its biologics license application (BLA) for the accelerated approval of Tividenofusp Alfa for the ...

Adolescent and young adult patients with face delayed diagnoses, financial hardships and gaps in specialized care, creating a ...

As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...

Investors are closely watching April 2, the long-anticipated “Liberation Day,” which has finally arrived. Financial markets are already getting jittery. Trump’s latest move to reshape trade policies ...

Revvity's stock rose after FDA approval of its Auto-Pure 2400 platform integrated with the T-SPOT.TB test, improving latent ...